NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/12/2025
Back to search
Official data from USPTO
MERCALIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MERCALIS
ST13
US500000097916626Class
35, 36, 41, 42, 45
Filing
97916626
Registration
7892673
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/12/2025
Trademark type
Word
Nice classes
35, 36, 41, 42, 45
Filing date
05/02/2023
Registration date
08/12/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/12/2025
Last transaction
08/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/20/2023
First use in commerce
09/20/2023
Drawing code
4
Owner type
03
Owner location
MORRISVILLE, NC, US
Examiner
STEEL, ALYSSA PALADINO
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MERCALIS INC.
T. I. (pessoa física)
Representatives
Larry L. Coats COATS & BENNETT, PLLC
Technical classification
Nice Classes
Class 35Class 36Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management and administration of pharmacy reimbursement programs; Managing and administering the distribution of prescription pharmaceutical samples to physicians and patients for pharmaceutical manufacturers; Business management and administration of patient co-pay reimbursement programs on behalf of pharmaceutical manufacturers; Business management and administration of financial assistance programs that provide patients with access to affordable medicinenamely business management and administration of enrollment and reimbursement programs for the purchase of medication and generally facilitating access to medications; Business management and administration of patient support programs for pharmaceutical manufacturers; Business management and administration of patient engagement programs for pharmaceutical manufacturers; Business management and administration of formularypatientpayer policy information for pharmaceuticalmedical devicediagnostic manufacturers; Business management and administration of educational engagements for Health Care Providersbusiness management and administration of efforts to educate healthcare providers on medicationsdisease status and standard of care; Management of the distribution of clinical trial medication and supplies on behalf of pharmaceutical manufacturers; Providing business marketing informationtracking pharmaceutical promotional programs for pharmaceutical manufacturers and evaluating and determining their effectiveness; Data management services in the field of pharmaceutical patient safetycollecting adverse product events datastoring the datareporting collected adverse product events data; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturerspromoting awareness of diseasespharmaceutical brandstreatment affordable options; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturersmarketing services in the nature of promotion of pharmaceutical manufacturers and disease treatment options via social media; Business information servicestracking payer coverage policies and related documentation and providing life sciences clients access to such in order to enhance their market access strategies and patient support programs; Life science business strategy consulting services for assisting clients with commercial assessmentscorporate and portfolio strategynew product planning and commercialization supportpricing and market access insights; Business assistance servicesenrolling patients of pharmaceutical manufacturers into support programs that enable patients to viewtrackmanage the support program wherein the patient support program provides pharmaceutical consumer product informationpayer coverage status updatesproviding business information regarding access to enrollment and reimbursement programs for the purchase of medications; Providing business information and news to the pharmaceutical and life sciences industries on legislative and regulatory developments as it impacts and relates to the pharmaceutical and life sciences industries within the copay or patient affordability space
Class 36
Payment servicesreimbursement payment processing in the field of pharmaceutical financial assistance programs and loyalty program payment processing services provided on behalf of pharmaceutical manufacturers for the purpose of delivering benefits to patients enrolled in pharmaceutical manufacturer-sponsored financial assistance programs; Pharmacy benefit manager (PBM) accumulator mitigation services and detecting claim activity indicative of a pharmacy benefit manager attempting to abuse the use of co-pay cards by not applying amounts paid by clients towards the patient's deductible or annual out-of-pocket expense; Anti-kickback and risk mitigation services for the pharmaceutical industryantikickback compliance services for assuring that patients who have full or partial federally funded drug coverage are excluded from utilizing co-pay cards
Class 41
Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturersproviding podcastsseminarsworkshopsvirtual and in-person presentations for educational purposes in the field of diseasespharmaceutical brandsaffordable healthcare options
Class 42
Quality assurance and quality control patient claim services for monitoring paid claims to patients from insurance or pharmaceutical entities to insure that specific business rules are being correctly applied to patient claims; Pharmacovigilance services for othersscientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical productsassessment of risks presented by certain pharmaceutical products or combinations thereofproduct safety testing and consultation related thereto in the field of pharmaceuticals; Pharmacovigilance services for othersmonitoring the quality of efficacy of pharmaceutical preparations; Providing online non-downloadable software for patient support servicesfor enrolling patients of pharmaceutical manufacturers in support programs that enables the patients to viewtrack and manage the support program wherein the patient support program provides pharmaceutical product and medication educationmedication adherence supportvisibility into medication delivery and case statusclinical support services including injection and product educational trainingaccess to financial assistance programspayer coverage status updatespatient engagement services and reminders and notifications
Class 45
Pharmacy benefit fraud monitoringinvestigation services related to pharmacy benefit insurance claims
Publications
History of USPTO decisions and trademark events.
38 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/23/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/23/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/18/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/16/2025
IUAF
USE AMENDMENT FILED
04/03/2025
EISU
TEAS STATEMENT OF USE RECEIVED
04/03/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2024
PUBO
PUBLISHED FOR OPPOSITION
08/13/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/10/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2024
GNRT
NON-FINAL ACTION E-MAILED
07/05/2024
CNRT
NON-FINAL ACTION WRITTEN
07/05/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/03/2024
DOCK
ASSIGNED TO EXAMINER
06/09/2024
DOCK
ASSIGNED TO EXAMINER
05/15/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/01/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/01/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/01/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/25/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/25/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/29/2024
GNRT
NON-FINAL ACTION E-MAILED
01/29/2024
CNRT
NON-FINAL ACTION WRITTEN
01/29/2024
DOCK
ASSIGNED TO EXAMINER
01/29/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/15/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/31/2023
NWAP
NEW APPLICATION ENTERED
05/05/2023
Continuous trademark protection
Get notified about every new filing that threatens MERCALIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.